Yes. Good quarterly.
Expanding applications for ARG 007. A true wonder drug.
Plenty of cash to finish Phase 1 trial.
They are doing everything possible to start the trial before the end of June.
The hold up was Shanghai but all sorted now and we should have news on results of those relevant studies over the next 2 to 3 weeks.
Phase 1 trial is so close now that I can smell it.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-3
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
72.0¢ |
Change
0.015(2.13%) |
Mkt cap ! $92.22M | |||
| Open | High | Low | Value | Volume |
| 68.5¢ | 72.0¢ | 68.5¢ | $45.51K | 64.70K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1128 | 70.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 73.0¢ | 54923 | 3 |
View Market Depth
| Last trade - 15.55pm 08/10/2024 (20 minute delay) ? |
| AGN (ASX) Chart |